$1.4MSeed, 12 January 2026
Seed funds pharma and CRO collaborations, AI imaging analysis and expansion to the US and EU.
- Amount
- $1.4M
- Stage
- Seed
- Announced
- 12 January 2026
- Lead
- Soulmates Ventures
- Other investors
- IndieBio New York
- Use of funds
- Seed funds pharma and CRO collaborations, AI imaging analysis and expansion to the US and EU.
- Checked
- Amount and date checked against the press source
- Source
- FluoSphera zips CHF 1.15M seed for 3D human organ models that cut drug failures techfundingnews.com